CLINICAL_TRIALS
trial_result
· 2024-07-10
Clinical Trial Update: Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease [Phase 3]
Summary
A Phase 3 long-term extension study of filgotinib in adults with Crohn's disease has been terminated, and the results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galapagos NV | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED | Results posted: 2024-07-10